CN1221625A

CN1221625A - Oral medicine for treating beri-beri

Info

Publication number: CN1221625A
Application number: CN 98121864
Authority: CN
Inventors: 冯子政
Original assignee: Individual
Current assignee: Individual
Priority date: 1998-11-20
Filing date: 1998-11-20
Publication date: 1999-07-07
Anticipated expiration: 2018-11-20
Also published as: CN1058635C

Abstract

A medicine by oral application for treating beriberi with distinct curative effect is prepared from 9 Chinese-medicinal materials such as atractylodes rhizome, phellodendron bark, dahurian angelica root, scutellaria root, pueraria root, etc. It can be used to cure the rheumatism of lower extremity with sure curative effect.

Description

The oral drugs of treatment beriberi

The present invention relates to a kind of oral drugs for the treatment of beriberi, this medicine also has certain curative effect to lower limb rheumatism.

From etiology and pathology, in middle medical knowledge was disputed, beriberi belongs to soaked the disease that is difficult to winding flesh table and causes for a long time; In doctor trained in Western medicine, beriberi is considered to belong to the disease that fungal infection causes.But, no matter still be medicine for external use, and the beriberic purpose of all inaccessible radical cure of existing beriberi according to the medicine of the theoretical treatment beriberi of developing of doctor trained in Western medicine according to theory of Chinese medical science from current practical situation.

The objective of the invention is to develop a kind of beriberic oral drugs that effect a radical cure.

After determining goal of the invention, the inventor goes through the research of more than ten years according to theory of Chinese medical science, has succeeded in developing a kind of beriberic medicine that effects a radical cure finally.

The core of this medicine is to contain Rhizoma Atractylodis 10～20% in this medicine by weight percentage, Cortex Phellodendri 15～20%, the Radix Angelicae Dahuricae 8～15%, Radix Scutellariae 5～15%, Radix Puerariae 10～15%, Rhizoma Et Radix Notopterygii 10～15%, cattle sunset 5～15%.Comparatively ideal scheme is also to contain FANGQI 0～15%, Caulis Akebiae 0～15% in this medicine.

In each component of said medicine, surpass the determined upper limit and will produce certain negative interaction, be lower than it down in limited time, curative effect is just not remarkable or invalid.

In the present invention, fully utilized the following effect of each drug component:

The hot warm nature of Rhizoma Atractylodis is strong goes into spleen, the dampness resolving depression, wards off bad odor, removes foul, expelling pathogenic factors from muscles table; The Cortex Phellodendri bitter cold is gone into Liver Channel and is walked the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, and fire removes damp and hot clearly mutually; The hot temperature of the Radix Angelicae Dahuricae, FANGXIANG are gone into stomach, row's taste are wet, the heresy of expelling pathogenic factors from muscles table and invigorate blood circulation etc.; The Radix Scutellariae bitter cold is gone into lung, is opened smelly reason, the clear branch pathogenic heat of losing heart; Stomach is put down, gone into to the sweet suffering of Radix Puerariae, and the merit that has light sun to deliver is driven away flesh table damp, plays rash and induces sweat; The hot temperature of Rhizoma Et Radix Notopterygii is walked urinary bladder channel, disperses the meridians ailment said due to cold or exposure; Niu Xi goes into kidney, priming is descending; FANGQI is walked part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels inducting the medicines into affected channel; Caulis Akebiae walks the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, diuretic dehumidifying.

In a word, the present invention carries out compatibility from theory of Chinese medical science, its total effect be fill up clearly, dehumidifying, expelling pathogenic factors from the exterior, thereby clear away the dampness and heat from internal organs, reach the purpose of radical cure.

Characteristics of the present invention are:

1, this medicine both can be made into electuary, can be made into forms such as capsule, oral liquid again;

2, this medicine is except that beriberi is had the specially good effect, and is also effective in cure to lower limb rheumatism;

3, this medicine does not have other negative interaction except that the anemia of pregnant woman prohibits clothes;

4, its manufacture method is simple;

5, overcome the drawback of existing medicine for external use, easy to use, skin there is not any damage.

Below, provide embodiments of the invention (seeing the following form).

	Example 1	Example 2	Example 3	Example 4	Example 5
	Example 1	Example 2	Example 3	Example 4	Example 5	Rhizoma Atractylodis	18％	10％	15％	12％	20％
Rhizoma Et Radix Notopterygii	10％	10％	15％	13％	15％	Rhizoma Atractylodis	18％	10％	15％	12％	20％
Rhizoma Et Radix Notopterygii	10％	10％	15％	13％	15％	The Radix Angelicae Dahuricae	12％	15％	15％	10％	8％
Cortex Phellodendri	15％	20％	15％	20％	17％	The Radix Angelicae Dahuricae	12％	15％	15％	10％	8％
Cortex Phellodendri	15％	20％	15％	20％	17％	Radix Puerariae	10％	15％	15％	15％	15％
Radix Scutellariae	5％	10％	10％	15％	15％	Radix Puerariae	10％	15％	15％	15％	15％
Radix Scutellariae	5％	10％	10％	15％	15％	Niu Xi	15％	5％	5％	5％	10％
Caulis Akebiae	15％	0	5％	5％	0	Niu Xi	15％	5％	5％	5％	10％
Caulis Akebiae	15％	0	5％	5％	0	FANGQI	0	15％	5％	5％	0

Through the clinic trial of inventor, do not found the recidivist so far to 1000 many cases patients.Practice is proof also, and to general beriberi patient, can effect a radical cure a course of treatment, and to serious patient, also can effect a radical cure two courses of treatment, and the patient of especially severe needs to effect a radical cure four courses of treatment at most.

Making and use method of the present invention is, after various drug components are dried, is ground into carefully not and mix homogeneously to scale, is mixed with per 15 grams of electuary one bag, and 6 bags are a course of treatment, take every day 3 times, each 1 bag after mixing it with hot water.Perhaps the medicine smalls for preparing is made capsule, the dose of each, every day and each course of treatment is identical with electuary.

In addition, the Caulis Akebiae also Zhu Ling of available equivalent replaces, and Niu Xike replaces with the Cortex Cinnamomi of equivalent.

Claims

1, a kind of oral drugs for the treatment of beriberi is characterized in that containing in this medicine (percentage by weight): Rhizoma Atractylodis 10～20%, Cortex Phellodendri 15～20%, the Radix Angelicae Dahuricae 8～15%, Radix Scutellariae 5～15%, Radix Puerariae 10～15%, Rhizoma Et Radix Notopterygii 10～15%, cattle sunset 5～15%.

2, the oral drugs of treatment beriberi according to claim 1 is characterized in that also containing in this medicine (percentage by weight) FANGQI 0～15%, Caulis Akebiae 0～15%.